Total Payments
$1,908
2024 Payments
$266.25
Companies
22
Transactions
119
Medicare Patients
3,229
Medicare Billing
$393,910
Payment Breakdown by Category
Food & Beverage$1,908 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,908 | 119 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $784.08 | 62 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $242.23 | 17 | $0 (2024) |
| BioDelivery Sciences International, Inc. | $126.82 | 4 | $0 (2021) |
| Scilex Pharmaceuticals Inc. | $104.59 | 6 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $74.45 | 5 | $0 (2023) |
| RedHill Biopharma Inc. | $70.50 | 1 | $0 (2021) |
| GRT US Holding, Inc. | $56.50 | 2 | $0 (2022) |
| Biosense Webster, Inc. | $54.73 | 1 | $0 (2017) |
| Indivior Inc. | $54.61 | 3 | $0 (2022) |
| Abbott Laboratories | $54.32 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $266.25 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($188.16) |
| 2023 | $400.16 | 28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($209.21) |
| 2022 | $344.69 | 28 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($216.53) |
| 2021 | $805.48 | 41 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($170.18) |
| 2020 | $19.68 | 1 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($19.68) |
| 2018 | $16.69 | 1 | Boston Scientific Corporation ($16.69) |
| 2017 | $54.73 | 1 | Biosense Webster, Inc. ($54.73) |
All Payment Transactions
119 individual payment records from CMS Open Payments — Page 2 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/28/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: Opioid Analgesic | ||||||
| 08/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Gastroenterology | ||||||
| 08/09/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: INSOMNIA | ||||||
| 08/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: Gastroenterology | ||||||
| 07/19/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: INSOMNIA | ||||||
| 07/17/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.42 | General |
| Category: Opioid Analgesic | ||||||
| 06/22/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.06 | General |
| Category: Opioid Analgesic | ||||||
| 06/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Gastroenterology | ||||||
| 06/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: Gastroenterology | ||||||
| 06/13/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Analgesic | ||||||
| 06/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Gastroenterology | ||||||
| 06/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Gastroenterology | ||||||
| 05/16/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: INSOMNIA | ||||||
| 04/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Gastroenterology | ||||||
| 02/27/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Analgesic | ||||||
| 02/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Gastroenterology | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Gastroenterology | ||||||
| 02/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: Gastroenterology | ||||||
| 01/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: Gastroenterology | ||||||
| 01/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $12.51 | General |
| Category: Gastroenterology | ||||||
| 01/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: Gastroenterology | ||||||
| 01/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Gastroenterology | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Gastroenterology | ||||||
| 12/22/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Gastroenterology | ||||||
| 12/13/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug), RELISTOR | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 345 | 1,312 | $196,723 | $107,081 |
| 2022 | 8 | 555 | 1,038 | $128,945 | $74,516 |
| 2021 | 10 | 1,753 | 4,738 | $301,351 | $173,383 |
| 2020 | 8 | 576 | 631 | $274,742 | $38,930 |
Total Patients
3,229
Total Services
7,719
Medicare Billing
$393,910
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 190 | 1,091 | $163,650 | $92,270 | 56.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 163 | $18,745 | $7,773 | 41.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $8,928 | $4,049 | 45.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $5,400 | $2,989 | 55.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 202 | 501 | $75,423 | $44,693 | 59.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 178 | $20,463 | $11,536 | 56.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 65 | 65 | $18,720 | $10,209 | 54.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 45 | 45 | $3,735 | $2,746 | 73.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $4,598 | $2,523 | 54.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $3,920 | $1,996 | 50.9% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 84 | 184 | $1,656 | $574.76 | 34.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 14 | $430.00 | $237.69 | 55.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 505 | 1,239 | $176,668 | $95,862 | 54.3% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 468 | 933 | $77,439 | $56,240 | 72.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 92 | 92 | $16,788 | $8,932 | 53.2% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 550 | 2,305 | $20,141 | $6,960 | 34.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 38 | 39 | $4,324 | $2,593 | 60.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $2,354 | $1,873 | 79.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 30 | 32 | $544.00 | $395.60 | 72.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2021 | 19 | 47 | $443.00 | $201.73 | 45.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 22 | $2,113 | $185.53 | 8.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 18 | 18 | $537.00 | $140.40 | 26.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 150 | 153 | $199,811 | $20,402 | 10.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 126 | 128 | $18,168 | $10,042 | 55.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 41 | 42 | $37,365 | $3,802 | 10.2% |
About Dr. Stephen Jones, MD
Dr. Stephen Jones, MD is a Emergency Medicine healthcare provider based in Rainbow City, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124069240.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Jones, MD has received a total of $1,908 in payments from pharmaceutical and medical device companies, with $266.25 received in 2024. These payments were reported across 119 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,908).
As a Medicare-enrolled provider, Jones has provided services to 3,229 Medicare beneficiaries, totaling 7,719 services with total Medicare billing of $393,910. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Pain Medicine, Family Medicine
- Location Rainbow City, AL
- Active Since 06/09/2006
- Last Updated 06/23/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1124069240
Products in Payments
- RELISTOR (Drug) $784.08
- XTAMPZA (Drug) $242.23
- BELBUCA (Drug) $107.14
- ZTLido (Drug) $104.59
- QUVIVIQ (Drug) $74.45
- MOVANTIK (Drug) $70.50
- Qutenza (Drug) $56.50
- Carto Smarttouch (Device) $54.73
- SUBLOCADE (Drug) $54.61
- Narcan (Drug) $45.00
- Aimovig (Biological) $40.51
- PROCLAIM (Device) $34.56
- BOTOX (Biological) $26.82
- WAVEWRITER ALPHA (Device) $23.66
- Vanta (Device) $19.87
- Proclaim IPG (Device) $19.76
- VYEPTI (Biological) $19.73
- IFUSE IMPLANT (Device) $19.66
- ANJESO (Drug) $18.69
- GENERAL THERAPIES (Device) $16.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.